Feedback / Questions
ondansetron ultra-low dose (AD04) - Adial
alhydrogel injectable (AD04) - ADvantage Therap
https://alz.confex.com/alz/2024/meetingapp.cgi/Paper/95657
Carmela R Abraham, PhD; Anita Fischer, PhD; Thomas Hoffmann, PhD; Agustin F Santana; Achim Schneeberger, MD; Sylvie Trembleau, PhD
Jun 20, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next